Efficacy of Genicular Block on Total Knee Arthroplasty Surgery

NCT06942702 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2026-05-19

No results posted yet for this study

Summary

The aim of this study is to investigate the postoperative pain relieving effect of preoperative genicular block in total knee arthroplasty surgery. The main questions it aims to answer are:

1. Do visual analog scale (VAS) scores decrease in patients who underwent geniculate block?
2. Does opioid consumption decrease in patients who underwent geniculate block?

Researchers will compare postoperative pain in patients who received genicular block with those who did not.One group of patients will be administered 0.25% bupivacaine with the geniculate block method. The other group will not undergo any intervention. Both groups will be administered intravenous morphine for postoperative analgesia.

Conditions

  • Total Knee Anthroplasty
  • Genicular Nerves Block

Interventions

DRUG

Genicular blocks (bupivakain)

Genicular block is a regional analgesic technique performed with USG

DRUG

Patient Control Analgesia (PCA) Morphine group

this group consists of the patients no any intervention preoperatively and they will be given morfin with PCA (Patient controlled analgesia) and paracetamol 3x1000 mg intravenous and diclofenac 75 mg intramuscular (if needed)

DRUG

Paracetamol (acetaminophen) + Diclofenac Sodium

All patients are given paracetamol (3x1000 mg) and diclofenac (if needed)

Sponsors & Collaborators

  • Mersin University

    lead OTHER

Principal Investigators

  • Mustafa Azizoglu, Associated Professor · Mersin university Faculty of Medicine, Department of Anesthesiology and Reanimation

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-20
Primary Completion
2026-08-15
Completion
2026-12-20

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06942702 on ClinicalTrials.gov